Your browser doesn't support javascript.
loading
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-ß signaling pathway.
Bokhari, Amber A; Baker, Tabari M; Dorjbal, Batsukh; Waheed, Sana; Zahn, Christopher M; Hamilton, Chad A; Maxwell, G Larry; Syed, Viqar.
Affiliation
  • Bokhari AA; Uniformed Services University, Department of Obstetrics and Gynecology, Bethesda, MD 20814, USA.
  • Baker TM; Uniformed Services University, Department of Obstetrics and Gynecology, Bethesda, MD 20814, USA.
  • Dorjbal B; Uniformed Services University, Department of Obstetrics and Gynecology, Bethesda, MD 20814, USA.
  • Waheed S; Uniformed Services University, Department of Obstetrics and Gynecology, Bethesda, MD 20814, USA.
  • Zahn CM; American College of Obstetricians and Gynecologists, Washington, DC 20024, USA.
  • Hamilton CA; Uniformed Services University, Department of Obstetrics and Gynecology, Bethesda, MD 20814, USA.
  • Maxwell GL; Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA.
  • Syed V; John P. Murtha Cancer Center at Water Reed National Military Medical Center, Bethesda, MD 20889, USA.
Oncotarget ; 7(43): 69733-69748, 2016 Oct 25.
Article in En | MEDLINE | ID: mdl-27626172
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signal Transduction / Transforming Growth Factor beta / Endometrial Neoplasms / Nestin Limits: Female / Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signal Transduction / Transforming Growth Factor beta / Endometrial Neoplasms / Nestin Limits: Female / Humans Language: En Year: 2016 Type: Article